Announced
Financials
Tags
Pending
Pharmaceuticals
Friendly
United States
Domestic
Majority
Single Bidder
Private
pharma
Acquisition
Synopsis
Pfizer, an American multinational pharmaceutical corporation, agreed to acquire Amplyx Pharmaceuticals, a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases. Financial terms were not disclosed. “We are deeply committed to helping patients suffering from infectious diseases, continuously seeking opportunities to build our portfolio of anti-infective therapies. We’ve already invested in assets that, if approved, could help address drug-resistant bacterial infections and critical viral infections; with this acquisition, we look forward to progressing the development of a novel anti-fungal as well,” Angela Lukin, Pfizer Hospital Global President.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.